The Residency Report: Clinical insights from the iStent infinite trial
iStent Infinite Trial: Key Clinical Insights for Glaucoma Treatment Glaucoma remains one of the leading causes of irreversible blindness worldwide, affecting millions of people. While traditional treatments like eye drops, laser therapy, and trabeculectomy have been the mainstay, minimally invasive glaucoma surgeries (MIGS) are revolutionizing patient care. Among these, the iStent Infinite has emerged as […]
The Residency Report: Clinical insights from the iStent infinite trial Read More »